141st APHA Annual Meeting

In This section

285172
Dollars and disparities: A longitudinal study of the effects of title v investments on select maternal and child health outcomes

Tuesday, November 5, 2013 : 9:30 AM - 9:50 AM

Kristina Rabarison, MS , National Coordinating Center for Public Health Services and Systems Research, University of Kentucky - College of Public Health, Lexington, KY
Glen Mays, PhD, MPH , College of Public Health, University of Kentucky, Lexington, KY
Proper financing of the public health system is integral to governmental public health's role in assuring that services delivery is available in every community. Maternal and Child Health investments, the Title V MCH Block Grants (Title V), vary widely across states and overtime. However, there is limited empirical evidence on the causes and consequences of these variations. The purpose of this study is to analyze the effects of Title V spending variations on select MCH outcomes (infant mortality, low birth weight, and teen birth rate) and health disparities. The effects of state fiscal capacity, fiscal effort, and fiscal generosity on Title V spending are measured as possible sources of variations. This ten-year quasi-experimental longitudinal study uses panel data constructed by linking data from: the Consolidated Federal Funds Report, Census of Governments, National Vital Statistics System – Birth Data, Title V Information System, Pregnancy Risk Assessment Monitoring System, Census Bureau's Population Estimates, and Medicaid eligibility for low-income children and pregnant women. Fixed-effect regression models are used to estimate the effects of Title V on each health outcome measures while controlling for socio-economic determinants of health. Measures of political economy influencing governmental decision-making are used as instrumental variables to control the effects of unmeasured heterogeneity in Title V spending that might distally influence health outcomes. This research is currently being conducted as the primary author's dissertation and will be completed by the 2013 APHA Annual Meeting. Findings will provide unbiased measures of the causes and consequences of Title V spending across states and over time, during a period with a national economic recession and new health care reform law (2000-2010). In addition, the findings will provide evidence to inform MCH policy and management of Title V spending to ensure target populations receive appropriate services and mitigate racial and ethnic health disparities.

Learning Areas:
Biostatistics, economics
Public health administration or related administration
Public health or related education
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy
Public health or related research

Learning Objectives:
Analyze the effects of Title V spending on service delivery process and utilization measures, such as pre-natal care Assess the effects of Title V spending on overall health outcomes, including infant mortality, teen pregnancy, and low birth weight Assess the effects of Title V spending variations on racial and ethnic disparities and test for effects heterogeneity i.e. test whether the changes in Title V spending across states and over time have stronger effects on minority and low-income populations

Keywords: Financing, Maternal and Child Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a 3rd year doctoral student at the University of Kentucky, College of Public Health. This abstract is based on my dissertation, which will be completed upon my graduation in May 2013. Since fall 2010, I worked as a research assistant at the National Coordinating Center for PHSSR, and currently serve as the President of the UK AcademyHealth Student Chapter. My research interest is PHSSR, specifically Public Health Finance.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.